Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Yuh ETF-Sparplan: 6 gebührenfreie ETFs zum Vermögensaufbau -w-
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
Trading-Depot
>
04.03.2025 07:00:19

AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability

AEVIS VICTORIA SA / Key word(s): Sales Result
AEVIS VICTORIA SA – Strong growth in 2024 revenue and improved profitability

04-March-2025 / 07:00 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 LR

Fribourg, 4 March 2025

AEVIS VICTORIA SA (AEVS.SW) – Strong growth in 2024 revenue and improved profitability

AEVIS VICTORIA SA (AEVIS) announces consolidated revenues of CHF 1.057 billion for the financial year 2024, an increase of 10.9% compared to the previous financial year (2023: CHF 953.0 million). This increase is driven by solid growth in the hospital and hotel sectors as well as the expansion of corporate activities.

Swiss Medical Network, the Group's healthcare division, achieved a turnover of CHF 808.0 million in 2024, compared with CHF 768.7 million in 2023, which represents an increase of 5.1%. Organic growth of 4.4% was supported by the expansion of medical services, the improvement of operational processes and the targeted integration of new healthcare centers. The impact of energy, wage and medical equipment costs remains a challenge for the entire Swiss hospital sector, but Swiss Medical Network is continuing its optimization efforts to strengthen its profitability.

MRH Switzerland SA, which operates the Group's hotels, continued to grow with a turnover of CHF 188.4 million in 2024 compared to CHF 170.5 million in 2023, an increase of 10.5%. of which 10.1% organic. This performance is based on an increase in occupancy rates, a continued upscaling of the properties and strong demand in the luxury tourism and wellness sectors.

Swiss Hotel Properties SA, which owns and manages the Group's hotel real estate assets, recorded a turnover of CHF 30.9 million in 2024, compared to CHF 24.2 million in 2023, an increase of 27.5%. This increase is mainly due to a higher rental income and an enlarged portfolio.

Based on these results, AEVIS expects a consolidated EBITDA of between CHF 85 million and CHF 95 million for the 2024 financial year.

AEVIS will continue its development strategy by consolidating its hospital activities, optimizing its hotel portfolio and strengthening the management of its real estate assets. The Group remains committed to sustainable and profitable growth.

The 2024 Annual Report will be published on 3 April 2025 and will include a detailed analysis of the Group's results and strategic outlook.

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 79 635 04 10

AEVIS VICTORIA SA - Investing for a better life
AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network Holding SA (77%, directly and indirectly), the only Swiss private network of hospitals present in the country's three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (30%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.

Figures in this press release are based on preliminary data and are subject to change when final results are released. EBITDA guidance represents the Group's best estimate as of the date of this press release.



End of Inside Information

2094595  04-March-2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2094595&application_name=news&site_id=finanzen_net~~~069d1026-6a45-454f-953c-2a2c4451f1d6

Analysen zu AEVIS VICTORIA SA

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
Zu diesem Datensatz liegen uns leider keine Daten vor.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Um 18 Uhr live: Vom Kryptoboom mit Wertpapieren einfach und sicher profitieren

Der Kryptomarkt erlebt eine neue Hochphase und immer mehr Investoren wollen an diesem Boom teilhaben. Doch wie lässt sich der Aufschwung nutzen, ohne sich mit komplizierter Kryptotechnologie auseinandersetzen zu müssen? Die Antwort erhalten Sie live im Webinar!

Schnell noch Plätze sichern!

Insiderkäufe und Verkäufe – Wall Street Live mit Tim Schäfer

📈 Insider-Trades enthüllt: Welche Aktien die Top-Manager jetzt kaufen! 📊

Willst du wissen, welche Aktien Insider wie CEOs und Vorstände gerade aufkaufen? In unserem neuesten Video analysieren wir mit Tim Schäfer die spannendsten Insider-Käufe und -Verkäufe – von Unternehmen, die stark gefallen sind, bis hin zu Ausnahmen wie Rheinmetall und Commerzbank. Warum investieren Top-Manager gerade jetzt? Welche Aktien sind langfristig interessant? 🤔

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Insiderkäufe und Verkäufe – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’418.88 19.08 S2S3VU
Short 13’696.54 13.49 UEBSLU
Short 14’192.55 8.85 UIDBSU
SMI-Kurs: 12’956.91 12.03.2025 12:38:34
Long 12’358.58 19.97 BEQSJU
Long 12’032.31 13.35 BM0SOU
Long 11’548.30 8.91 B2ZSOU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}